» Articles » PMID: 36016833

Electroacupuncture Improves TBI Dysfunction by Targeting HDAC Overexpression and BDNF-associated Akt/GSK-3β Signaling

Overview
Specialty Cell Biology
Date 2022 Aug 26
PMID 36016833
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Acupuncture or electroacupuncture (EA) appears to be a potential treatment in acute clinical traumatic brain injury (TBI); however, it remains uncertain whether acupuncture affects post-TBI histone deacetylase (HDAC) expression or impacts other biochemical/neurobiological events.

Materials And Methods: We used behavioral testing, Western blot, and immunohistochemistry analysis to evaluate the cellular and molecular effects of EA at LI4 and LI11 in both weight drop-impact acceleration (WD)- and controlled cortical impact (CCI)-induced TBI models.

Results: Both WD- and CCI-induced TBI caused behavioral dysfunction, increased cortical levels of HDAC1 and HDAC3 isoforms, activated microglia and astrocytes, and decreased cortical levels of BDNF as well as its downstream mediators phosphorylated-Akt and phosphorylated-GSK-3β. Application of EA reversed motor, sensorimotor, and learning/memory deficits. EA also restored overexpression of HDAC1 and HDAC3, and recovered downregulation of BDNF-associated signaling in the cortex of TBI mice.

Conclusion: The results strongly suggest that acupuncture has multiple benefits against TBI-associated adverse behavioral and biochemical effects and that the underlying mechanisms are likely mediated by targeting HDAC overexpression and aberrant BDNF-associated Akt/GSK-3 signaling.

Citing Articles

Serum exosomes miR-206 and miR-549a-3p as potential biomarkers of traumatic brain injury.

Yang Y, Wang Y, Li P, Bai F, Liu C, Huang X Sci Rep. 2024; 14(1):10082.

PMID: 38698242 PMC: 11066004. DOI: 10.1038/s41598-024-60827-8.


Electroacupuncture exerts prolonged analgesic and neuroprotective effects in a persistent dental pain model induced by multiple dental pulp injuries: GABAergic interneurons-astrocytes interaction.

Ballon Romero S, Fuh L, Hung S, Lee Y, Huang Y, Chien S Front Immunol. 2023; 14:1213710.

PMID: 37954604 PMC: 10639134. DOI: 10.3389/fimmu.2023.1213710.


Therapy of traumatic brain injury by modern agents and traditional Chinese medicine.

Wei C, Wang J, Yu J, Tang Q, Liu X, Zhang Y Chin Med. 2023; 18(1):25.

PMID: 36906602 PMC: 10008617. DOI: 10.1186/s13020-023-00731-x.

References
1.
Kim H, Rowe M, Ren M, Hong J, Chen P, Chuang D . Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther. 2007; 321(3):892-901. DOI: 10.1124/jpet.107.120188. View

2.
Zhong J, Cheng C, Liu H, Huang Z, Wu Y, Teng Z . Bexarotene protects against traumatic brain injury in mice partially through apolipoprotein E. Neuroscience. 2016; 343:434-448. DOI: 10.1016/j.neuroscience.2016.05.033. View

3.
Leeds P, Yu F, Wang Z, Chiu C, Zhang Y, Leng Y . A new avenue for lithium: intervention in traumatic brain injury. ACS Chem Neurosci. 2014; 5(6):422-33. PMC: 4063503. DOI: 10.1021/cn500040g. View

4.
Li S, Wang Y, Jiang Z, Huai Y, Liao J, Lynch K . Impaired Cognitive Performance in Endothelial Nitric Oxide Synthase Knockout Mice After Ischemic Stroke: A Pilot Study. Am J Phys Med Rehabil. 2018; 97(7):492-499. PMC: 6008172. DOI: 10.1097/PHM.0000000000000904. View

5.
Fleminger S, Oliver D, Lovestone S, Rabe-Hesketh S, GIORA A . Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication. J Neurol Neurosurg Psychiatry. 2003; 74(7):857-62. PMC: 1738550. DOI: 10.1136/jnnp.74.7.857. View